Showing results (191-200 of 293) with videos related to

Sort By:
Pageof 30
Physics in Medicine and Biology|July 28, 2023
A bi-directional beam-line energy ramping for efficient patient treatment with scanned proton therapyOxana Actis, Alexandre Mayor, David Meer, et al.
The Journal of Biological Chemistry|August 25, 1981
The pyridine nucleotide cycle. Studies in Escherichia coli and the human cell line D98/AH2D Hillyard, M Rechsteiner, P Manlapaz-Ramos, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
Identification of an activation region in the proteasome activator REGalphaZ Zhang, A Clawson, C Realini, et al.
European Radiology|May 24, 2018
Meniscal pathologies on MRI correlate with increased bone tracer uptake in SPECT/CTJan Rechsteiner, Michael T Hirschmann, Milos Dordevic, et al.
Physics in Medicine and Biology|June 6, 2017
A beam monitoring and validation system for continuous line scanning in proton therapyG Klimpki, S Psoroulas, C Bula, et al.
The EMBO Journal|July 4, 2001
Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and betaJ Li, X Gao, J Ortega, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 21, 2026
Atypical Ductular Reactions Are a Distinct Regenerative Phenomenon in Hepatocellular Carcinoma (HCC) Patients after Transarterial ChemoembolizationOrnella Wolff, Adrian Kobe, Laure-Alix Clerbaux, et al.
Virchows Archiv : an International Journal of Pathology|October 3, 2013
Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinomaMatthias Rössle, Michèle Sigg, Jan H Rüschoff, et al.
The Journal of Biological Chemistry|November 5, 1997
Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activatorsC Realini, C C Jensen, Z Zhang, et al.
Journal of Virology|December 7, 2007
Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infectionMarkus P Rechsteiner, Christoph Berger, Ludwig Zauner, et al.
Pageof 30